Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
The prevalence of chronic kidney disease (CKD) is estimated to be 15.8% in Africa. Across the continent, diagnosis and treatment rates are low, with most patients being diagnosed in the later stages of disease. This is due to some cases of CKD, particularly in the earlier stages, presenting asymptomatically. Consequently, CKD imposes a significant burden on health systems, particularly due to increased risk of cardiovascular (CV) complications, and kidney replacement therapy (KRT). The objective of this study was to project the clinical and environmental burden of CKD between 2025 and 2030 in Egypt and Morocco.
Virtual populations representative of Egypt and Morocco were generated between 2025 and 2030, using a microsimulation model. Individuals were assigned discrete characteristics such as age, sex, and CKD status, based on country-specific demographic and epidemiological data. Where country-specific data was unavailable, proxy data was used. Each year, modelled individuals progressed through CKD stages based on age-related estimated glomerular filtration rate decline rates and related comorbidities, to generate population-level projections of the clinical burden of CKD. Greenhouse gas (GHG) emissions associated with in-centre haemodialysis (HD) were estimated and scaled to per-patient healthcare resource utilisation estimates of CKD patients on HD. Hospitalisation-specific GHG emission estimates were also generated based on the average emissions produced daily on a general ward. These estimates were then scaled to produce population-level estimates in Egypt and Morocco.
CKD prevalence and its clinical burden were projected to rise substantially in both countries. CKD prevalence increased from 4.8% to 6.1% in Egypt and from 4.1% to 4.7% in Morocco between 2025 and 2030, with only 6–7% of cases expected to be clinically diagnosed and recorded. Between 2025 and 2030, there were 6,762 incident cases of heart failure (HF), 14,027 incident cases of myocardial infarction (MI), and 5,515 incident cases of stroke in the diagnosed CKD population in Egypt. In Morocco, there were 4,665, 11,737, and 5,319 incident cases of HF, MI and stroke, respectively. By 2030, there were a projected total of 227,758 and 75,599 deaths among diagnosed CKD patients in Egypt and Morocco, respectively. The prevalence of in-centre HD was also projected to increase to 83,048 and 42,056 cases by 2030 in Egypt and Morocco, corresponding to the emission of 1,500 and 890 tonnes of GHG emissions, respectively. Over 6 years, there were 2.3 million and 4.9 million hospitalisation days, resulting in 59,000 and 149,000 tonnes in GHG emissions in Egypt and Morocco.
This study demonstrates the large future clinical and environmental burden of CKD in Egypt and Morocco within the current standard of care. The use of proxy data may limit the representativeness of our findings of the burden of CKD in these diverse populations. The high prevalence of CV complications, KRT, and hospitalisations underscore the need for earlier CKD detection and improved surveillance, such as the implementation of national and regional strategies for early screening and treatment, alongside integrated approaches for environmental sustainability to mitigate the projected clinical and environmental burden of CKD.
